Bound By Blood – BPDCN

The Leukemia and Lymphoma Society lists blastic plasmacytoid dendritic cell neoplasm (BPDCN) as a rare blood cancer that often comes with a poor prognosis.

That’s why when Robert, 69, learned he had BPDCN, he and his wife, Valerie, found it hard to share the news with their children. But in this episode of Medical Stories, one member of their family ends up offering exactly what Robert needs to help manage his condition.

Featuring renowned expert: Andrew A. Lane, hematologist oncologist at Dana-Farber Cancer Institute and professor at Harvard Medical School.